Filing Details

Accession Number:
0001127602-13-016097
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-08 13:43:17
Reporting Period:
2013-05-06
Filing Date:
2013-05-08
Accepted Time:
2013-05-08 13:43:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
799729 Parexel International Corp PRXL Services-Commercial Physical & Biological Research (8731) 042776269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552687 Gadi Saarony C/O Parexel International
195 West Street
Waltham MA 02451
Corp. Sr. Vp, Crs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-06 2,500 $9.12 7,400 No 4 M Direct
Common Stock Acquisiton 2013-05-06 7,500 $23.82 14,900 No 4 M Direct
Common Stock Disposition 2013-05-06 10,000 $44.07 4,900 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-06 2,500 $0.00 2,500 $9.12
Common Stock Stock Option (Right to Buy) Disposition 2013-05-06 7,500 $0.00 7,500 $23.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-03-20 No 4 M Direct
7,500 2018-07-21 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $44.01- $44.13. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
  2. Currently exercisable
  3. Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant.